Figure 2From: Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case reportTemporal changes in alpha-feto-protein expression. The duration of treatment with sorafenib is indicated in the gray bar. Initiation of sorafenib resulted in a dramatic reduction in serum AFP levels.Back to article page